Case 3: Faricimab in a neovascular nAMD patient with persistent fluid

Video

Dr. Khanani discusses how switching to faricimab helped resolve persistent intraretinal and subretinal fluid in a patient and extended treatment intervals leading to decreased patient burden.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Sponsored by Roche

      Newsletter

      Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

      Subscribe Now!
      © 2025 MJH Life Sciences

      All rights reserved.